Biogen Idec Investors

Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Technology:
NeuroPharmacology
Headquarters:
Weston, Massachusetts, United States
Acquisitions Number:
9
Funding Status:
IPO
Investment Stage:
Early Stage Venture, Late Stage Venture
Founded Date:
1978
Number Of Exists:
15
Estimated Revenue:
$1B to $10B
Employee Number:
5001-10000
Industry:
Biotechnology, Health Care, Neuroscience, Therapeutics
Investor Type:
Venture Capital